Founded in 2012, GenBody Inc. creates innovative technologies for the development of raw materials for diagnostic use such as ELISA and rapid diagnostic tests (RDTs).
With over 15 years combined experience in the diagnostic industry and through vast bio-networks between several key institutes, universities, and hospitals, our core strength is in R&D; we specialized in developing monoclonal antibodies and recombinant antigens in-house at our facility in South Korea.